Hidradenitis Suppurativa clinical trials at UC Irvine
1 research study open to eligible people
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Irvine, California and other locations
Our lead scientists for Hidradenitis Suppurativa research studies include Natasha Mesinkovska, MD.